BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26428374)

  • 41. Epstein-Barr virus latent membrane protein 2B (LMP2B) co-localizes with LMP2A in perinuclear regions in transiently transfected cells.
    Lynch DT; Zimmerman JS; Rowe DT
    J Gen Virol; 2002 May; 83(Pt 5):1025-1035. PubMed ID: 11961256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 5' Coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio.
    Franken M; Annis B; Ali AN; Wang F
    J Virol; 1995 Dec; 69(12):8011-9. PubMed ID: 7494314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.
    Swanson-Mungerson MA; Caldwell RG; Bultema R; Longnecker R
    J Virol; 2005 Jun; 79(12):7355-62. PubMed ID: 15919890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The latent membrane protein 2 gene of Epstein-Barr virus is important for efficient B cell immortalization.
    Brielmeier M; Mautner J; Laux G; Hammerschmidt W
    J Gen Virol; 1996 Nov; 77 ( Pt 11)():2807-18. PubMed ID: 8922475
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase Lyn.
    Rovedo M; Longnecker R
    J Virol; 2008 Sep; 82(17):8520-8. PubMed ID: 18579586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation.
    Shah KM; Stewart SE; Wei W; Woodman CB; O'Neil JD; Dawson CW; Young LS
    Oncogene; 2009 Nov; 28(44):3903-14. PubMed ID: 19718044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase.
    Chen SY; Lu J; Shih YC; Tsai CH
    J Virol; 2002 Sep; 76(18):9556-61. PubMed ID: 12186939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of the phosphorylation status of Epstein-Barr virus LMP2A in epithelial cells.
    Scholle F; Longnecker R; Raab-Traub N
    Virology; 2001 Dec; 291(2):208-14. PubMed ID: 11878890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation.
    Konishi K; Maruo S; Kato H; Takada K
    J Gen Virol; 2001 Jun; 82(Pt 6):1451-1456. PubMed ID: 11369890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. C-terminal domain of the Epstein-Barr virus LMP2A membrane protein contains a clustering signal.
    Matskova L; Ernberg I; Pawson T; Winberg G
    J Virol; 2001 Nov; 75(22):10941-9. PubMed ID: 11602734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lysine-independent ubiquitination of Epstein-Barr virus LMP2A.
    Ikeda M; Ikeda A; Longnecker R
    Virology; 2002 Aug; 300(1):153-9. PubMed ID: 12202215
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals.
    Caldwell RG; Wilson JB; Anderson SJ; Longnecker R
    Immunity; 1998 Sep; 9(3):405-11. PubMed ID: 9768760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction.
    Miller CL; Lee JH; Kieff E; Burkhardt AL; Bolen JB; Longnecker R
    Infect Agents Dis; 1994; 3(2-3):128-36. PubMed ID: 7812651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evasion of affinity-based selection in germinal centers by Epstein-Barr virus LMP2A.
    Minamitani T; Yasui T; Ma Y; Zhou H; Okuzaki D; Tsai CY; Sakakibara S; Gewurz BE; Kieff E; Kikutani H
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11612-7. PubMed ID: 26305967
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.
    Miller CL; Lee JH; Kieff E; Longnecker R
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):772-6. PubMed ID: 8290598
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors.
    Higuchi M; Izumi KM; Kieff E
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4675-80. PubMed ID: 11296297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo.
    Merchant M; Caldwell RG; Longnecker R
    J Virol; 2000 Oct; 74(19):9115-24. PubMed ID: 10982358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
    Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
    J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway.
    Swart R; Ruf IK; Sample J; Longnecker R
    J Virol; 2000 Nov; 74(22):10838-45. PubMed ID: 11044134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent membrane protein 2: a role for C-terminal Src kinase.
    Scholle F; Longnecker R; Raab-Traub N
    J Virol; 1999 Jun; 73(6):4767-75. PubMed ID: 10233937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.